Company intelligence / Profile preview

Biosensors International Group, Ltd.

Singapore, Central Singapore, Singaporebiosensors.com ↗

Ownership: Private
Employees: ~469
Development stage: Commercial

Overview

Biosensors International develops, manufactures, and markets innovative medical devices for interventional cardiology and critical care procedures. Their flagship products include the BioMatrix family of drug-eluting stents and BioFreedom DCS, which have demonstrated superior safety and efficacy in clinical trials.

Therapeutic areas: OtherCardiovascular
Modalities: Drug-eluting stentsBare metal stentsBalloon dilatation cathetersCritical care catheter systems
Industry: Surgical Medical Devices

Drug pipeline

3 assets

BioFreedom Ultra

Commercial

Indications: Cardiovascular disease

2 more assets in the full pipeline.

Request access →

Partnerships

TerumoDevax, Inc.Xtent, Inc.Shandong Weigao (joint venture)

Beyond the preview

Go deeper on Biosensors International Group, Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biosensors International Group, Ltd..

Explore the full profile